| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |